Corrigendum to ‘Reverse Remodeling Effects of Sacubitril-Valsartan: Structural and Functional Optimization in Stage C Heart Failure’ [American Journal of Cardiology 210 (2024) 249-255, (S0002914923011190), (10.1016/j.amjcard.2023.09.110)]

Sara Kalantari, Daniel Oren, Diego Medvedofsky, Akhil Narang, Teruhiko Imamura, Sarah Tayazime, Gene H. Kim, Jayant Raikhelkar, Gabriel Sayer, Roberto M. Lang, Nir Uriel*

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Abstract

The authors apologize for the misspelling of co-author Dr. Kalantari's name. The manuscript has been corrected. The authors would like to apologize for any inconvenience caused.

Original languageEnglish
Pages (from-to)127
Number of pages1
JournalAmerican Journal of Cardiology
Volume218
DOIs
StatePublished - 2024/05/01

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Corrigendum to ‘Reverse Remodeling Effects of Sacubitril-Valsartan: Structural and Functional Optimization in Stage C Heart Failure’ [American Journal of Cardiology 210 (2024) 249-255, (S0002914923011190), (10.1016/j.amjcard.2023.09.110)]'. Together they form a unique fingerprint.

Cite this